Cedar Brook Corporate Center
Bruce Simon
4A Cedar Brook Drive
Cranbury, NJ 08512
Office: (609) 655.5400
Email: bsimon@easternproperties.net

Top New Jersey Pharma Headlines of 2015

Share on Facebook0Tweet about this on TwitterShare on LinkedIn0Share on Google+0

shutterstock_1959835

Burgeoning strength in the economy and a robust market is driving growth within New Jersey’s bio-pharmaceutical life sciences cluster, as it now plays host to more than 3,000 companies in the pharmaceuticals and life sciences industries. This figure supports a significant rise in high quality employment and leasing activity across the region, and a remarkable increase in facility expansions and in mergers and acquisitions.

We have taken a look back over the previous year’s leading pharmaceutical and biotech headlines and summarized some of the most significant news developments:

January 2015
Major pharmaceutical companies start 2015 with mergers

June 2015
16 of the 27 New Drugs Approved by FDA Came from Companies with Footprint in New Jersey

August 2015
Modest decline in demand, but pharma market commercial real estate remains strong in NJ

September 2015
Rutgers announces ‘N.J.-Israel Healthy, Functional and Medical Foods Alliance’

September 2015
Report to highlight N.J. drugmakers’ progress in fight against cancer

October 2015
FDA awards $4.9M to N.J.-based pharma manufacturing research consortium

November 2015
Biotech and life sciences: Alive and well in New Jersey

December 2015
Vertice Pharma Completes Acquisition of VistaPharm

December 2015
The Top 10 Stocks of 2015: Biotech Companies And Netflix

January 2016
First-of-a-kind drug approvals continued rise in 2015

Leave a Reply

Your email address will not be published. Required fields are marked *